CHD1L and neoplasm: One potential target is Chromodomain helicase DNA-binding protein 1-like (CHD1L, also known as ALC1), which is an oncogene that promotes tumor progression, metastasis, and multidrug resistance (MDR) in many cancers, including breast cancer [4,5].